Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182R-6 (original) (raw)

References

• Berkenstam, A., Glaumann, H., Martin, M., Gustafsson, JÅ & Norsted, G. (1989). Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells. Mol Endocrinol 3: 22–28.
  Article CAS Google Scholar
• Berthois, Y., Dong, X. F., Roux-Dossetto, M. & Martin, P. M. (1990). Expression of estrogen receptor and its messenger ribonucleic acid in the MCF-7 cell line: multiparametric analysis of its processing and regulation by estradiol. Mol Cell Endocrinol 74: 11–20.
  Article CAS Google Scholar
• Borrás, M., Hardy, L., Lempereue, F., El Khissiin, A. H., Legros, N., Gol-Winkler, R. & Leclercq, G. (1994). Estrogen-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J Steroid Biochem Mol Biol 48: 325–336.
  Article Google Scholar
• Borrás, M., Laios, I., El Khissiin, A., Seo, H. S., Lempereur, F., Legros, N. & Leclercq, G. (1996). Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 57: 203–213.
  Article Google Scholar
• Briand, P. & Lykkesfeldt, A. E. (1984). Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to grow at low serum concentration. Cancer Res 44: 1114–1119.
  CAS PubMed Google Scholar
• Clarke, R. & Brünner, N. (1996). Acquired estrogen independence and antiestrogen resistance in breast cancer. Estrogen receptor driven phenotypes? Trends Endocrinol Metab 7: 291–301.
  Article CAS Google Scholar
• Dauvois, S., Danielian, P. S., White, R. & Parker, M. G. (1992). Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci USA 89: 4037–4041.
  Article CAS Google Scholar
• EORTC Breast Co-operative Group (1980). Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second EORTC workshop, held on 16–17 March, 1979, in the Netherlands Cancer Institute. Eur J Cancer 16: 1513–1515.
• Gibson, M. K., Nemmers, L. A., Beckman, W. C., Davis, V. L., Curtis, S. W. & Korack, K. S. (1991). The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of ER in uterine tissue. Endocrinology 129: 2000–2010.
  Article CAS Google Scholar
• Herman, M. E. & Katzenellenbogen, B. S. (1996). Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen. J Steroid Biochem Mol Biol 59: 121–134.
  Article CAS Google Scholar
• Horwitz, K. B. & McGuire, W. L. (1978). Nuclear mechanisms of estrogen action. J Biol Chem 253: 8185–8191.
  CAS PubMed Google Scholar
• Howell, A., DeFriend, D. J., Robertson, J. F. R., Blamey, R. W. & Walton, P. (1995). Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer. Lancet 345: 29–30.
  Article CAS Google Scholar
• Hyder, S. M., Chiappetta, C., Murthy, L. & Stancel, G. M. (1997). Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780. Cancer Res 57: 2547–2549.
  CAS PubMed Google Scholar
• Johnston, S. R. D., Saccani-Jotti, G., Smith, I. E., Salter, J., Newby, J., Coppen, M., Ebbs, S. R. & Dowsett, M. (1995). Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res 55: 3331–3338.
  CAS PubMed Google Scholar
• Katzenellenbogen, B. S. (1991). Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy. J Natl Cancer Inst 83: 1434–1444.
  Article CAS Google Scholar
• Laborda, J. (1991). 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19: 3998
  Article CAS Google Scholar
• Larsen, S. S., Madsen, M. W., Jensen, B. L. & Lykkesfeldt, A. E. (1997). Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness. Int J Cancer 72: 1129–1136.
  Article CAS Google Scholar
• Liang, P. & Pardee, A. B. (1992). Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967–970.
  Article CAS Google Scholar
• Lykkesfeldt, A. E. (1996). Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer. Acta Oncol 35: 9–14.
  Article Google Scholar
• Lykkesfeldt, A. E., Madsen, M. W. & Briand, P. (1994). Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Cancer Res 54: 1587–1595.
  CAS Google Scholar
• Lykkesfeldt, A. E., Larsen, S. S. & Briand, P. (1995). Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment. Int J Cancer 61: 529–534.
  Article CAS Google Scholar
• Madsen, M. W., Reiter, B. E. & Lykkesfeldt, A. E. (1995). Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7/TAMR/TAMR-1 compared to the parental MCF-7 cell line. Mol Cell Endocrinol 109: 197–207.
  Article CAS Google Scholar
• Masamura, S., Santner, S. J., Heitjan, D. F. & Santen, R. J. (1995). Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab 80: 2918–2925.
  CAS PubMed Google Scholar
• Mouridsen, H., Palshof, T., Patterson, J. & Battersby, L. (1978). Tamoxifen in advanced breast cancer. Cancer Treat Rev 5: 131–141.
  Article CAS Google Scholar
• Osborne, C. K., Yochmowitz, M. G., Knight, W. A. & McGuire, W. L. (1980). The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884–2888.
  Article CAS Google Scholar
• Osborne, C. K., Coronado-Heinsohn, E. B., Hilsenbeck, S. G., McCue, B. L., Wakeling, A. E., McClelland, R. A., Manning, D. L. & Nicholson, R. I. (1995). Comparison of the effects of pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. J Natl Cancer Inst 87: 746–750.
  Article CAS Google Scholar
• Pink, J. J. & Jordan, V. C. (1996). Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res 56: 2321–2330.
  CAS PubMed Google Scholar
• Robertson, J. F. R. (1996). Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer 73: 5–12.
  Article CAS Google Scholar
• Saceda, M., Lippman, M. E., Chambon, P., Lindsey, R. L., Ponglikitmongkol, M., Puente, M. & Martin, M. B. (1988). Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol 2: 1157–1162.
  Article CAS Google Scholar
• Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E. & Chambon, P. (1989). The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59: 477–487.
  Article CAS Google Scholar
• van Agthoven, T., van Agthoven, T. L. A., Dekker, A., Foekens, J. A. & Dorssers, L. C. J. (1994). Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations. Mol Endocrinol 8: 1474–1483.
  CAS PubMed Google Scholar
• Wakeling, A. E., Dukes, M. & Bowler, J. (1991). A potent specific pure antiestrogen with clinical potential. Cancer Res 51: 3867–3873.
  CAS PubMed Google Scholar
• Wakeling, A. E. (1993). Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens?. J Steroid Biochem Mol Biol 47: 107–111.
  Article CAS Google Scholar

Download references